| Date Filed | Type | Description |
| 01/24/2023 |
4
| Bhatt Elizabeth (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $0.4688, valued at
$14.1k
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2022 |
4
| Bhatt Elizabeth (Chief Bus. & Strategy Officer) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Granted 17,250 shares
@ $0
Granted 80,500 options to buy
@ $8.29, valued at
$667.3k
|
|
| 01/06/2022 |
4
| Bhatt Elizabeth (Chief Bus. & Strategy Officer) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Granted 31,500 shares
@ $0 |
|
| 10/08/2021 |
4
| Bhatt Elizabeth (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $11.36, valued at
$454.4k
|
|
| 08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2021 |
4
| Bhatt Elizabeth (Director) has filed a Form 4 on Locust Walk Acquisition Corp.|
Txns:
| Disposed of 17,500 options to buy
@ $0 |
|
| 01/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/04/2020 |
3
| Bhatt Elizabeth (Chief Bus. & Strategy Officer) has filed a Form 3 on Applied Molecular Transport Inc. |
| 02/25/2019 |
4
| Bhatt Elizabeth (COO) has filed a Form 4 on Achaogen, Inc.|
Txns:
| Sold 971 shares
@ $0.89, valued at
$864.2 |
|
| 01/23/2019 |
4
| Bhatt Elizabeth (COO) has filed a Form 4 on Achaogen, Inc.|
Txns:
| Granted 156,500 shares
@ $0 |
|
| 09/13/2018 |
4
| Bhatt Elizabeth (COO) has filed a Form 4 on Achaogen Inc|
Txns:
| Granted 65,000 options to buy
@ $4.79, valued at
$311.4k
|
|
| 08/06/2018 |
3
| Bhatt Elizabeth (COO) has filed a Form 3 on Achaogen Inc |